Roche Diagnostics Portfolio Update 2022 Analyst Investor Event

Roche Diagnostics presented a portfolio update at the AACC Analyst & Investor Event in Chicago on 26 July 2022, highlighting structural growth in the diagnostics division. Key metrics showed diagnostics reaching ~31% of group sales by HY 2022, with core operating profit doubling and R&D investment increasing by 40%. Growth was driven by COVID-19 pandemic response and investments in innovative diagnostic technologies.